http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108210725-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-8969 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-268 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-481 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-815 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-486 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-284 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8969 |
| filingDate | 2018-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108210725-B |
| titleOfInvention | Blood-increasing medicine composition and preparation method thereof |
| abstract | The invention discloses a blood-increasing medicine composition, which consists of the following raw materials: 20-60 parts of raw astragalus membranaceus, 10-50 parts of fried bighead atractylodes rhizome, 20-60 parts of caulis spatholobi, 10-50 parts of wolfberry fruit, 5-20 parts of semen cuscutae, 10-50 parts of rhizoma polygonati, 1-8 parts of cinnamon, 1-8 parts of asarum and 1-8 parts of borneol. The invention also discloses a preparation method of the blood-increasing medicine composition. The blood-increasing medicine composition has certain hematology protection effect on leucopenia caused by tumor chemotherapy, and particularly has obvious advantages in the aspects of increasing leucocyte count, improving traditional Chinese medicine symptoms and improving life quality in the later treatment period. |
| priorityDate | 2018-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 65.